Description
PROCYSBI (cysteamine bitartrate) delayed-release capsules, used for the treatment of patients with nephropathic cystinosis
Inotuzumab ozogamicin is used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia. It is administered by intravenous infusion in a doctor’s office or clinic.
How can 1 go about obtaining PROCYSBI ?
If PROCYSBI (cysteamine bitartrate) capsules are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).
Note:
We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.
NEWS / UPDATES
- For PROCYSBI (cysteamine bitartrate) delayed-release capsules Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
- New Dosage Formulation of Procysbi to Get FDA Review For More Details